Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 321 participants.

Also called NCT02749890

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 321 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02749890
Other papers using this trial's data
  • Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial Diabetes care, 2020-06 DOI, PubMed 32295808, PMC7245357 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02749890. Randomized; no masking; primary purpose treatment. Start 2016-05-09 (actual); primary completion 2018-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Acronym
LIXILAN JP-O1
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Insulin glargine/Lixisenatide (HOE901/AVE0010)
Intervention (Drug)
Lixisenatide (AVE0010)
Intervention (Drug)
Oral anti-diabetic drugs
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct02749890
Content hash
fb9ecb18f268a32d1bfddeaf102174de224db915335cfb9b300309f1293dff5b